カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の経口避妊薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Oral Contraceptive Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19480）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19480
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：106
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の経口避妊薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

経口避妊薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の経口避妊薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

経口避妊薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・長時間作用型避妊薬、短時間作用型避妊薬、緊急避妊薬

用途別セグメントは次のように区分されます。
・病院、薬局、その他

世界の経口避妊薬市場の主要な市場プレーヤーは以下のとおりです。
・Bayer、Pfizer、Teva Pharmaceutical、Merck、Actavis、Johnson & Johnson、Gedeon Richter、Novo Nordisk A/S、ZiZhu、Baijingyu、Huazhong

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、経口避妊薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な経口避妊薬メーカーの企業概要、2019年～2022年までの経口避妊薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な経口避妊薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別経口避妊薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの経口避妊薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での経口避妊薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および経口避妊薬の産業チェーンを掲載しています。
・第13、14、15章では、経口避妊薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 経口避妊薬の概要
- 種類別分析（2017年vs2021年vs2028年）：長時間作用型避妊薬、短時間作用型避妊薬、緊急避妊薬
- 用途別分析（2017年vs2021年vs2028年）：病院、薬局、その他
- 世界の経口避妊薬市場規模・予測
- 世界の経口避妊薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Bayer、Pfizer、Teva Pharmaceutical、Merck、Actavis、Johnson & Johnson、Gedeon Richter、Novo Nordisk A/S、ZiZhu、Baijingyu、Huazhong
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：長時間作用型避妊薬、短時間作用型避妊薬、緊急避妊薬
・用途別分析2017年-2028年：病院、薬局、その他
・経口避妊薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・経口避妊薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・経口避妊薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・経口避妊薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・経口避妊薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Oral Contraceptive Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Oral Contraceptive Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Oral Contraceptive Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Long-acting Contraceptives segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Oral Contraceptive Drugs include Bayer, Pfizer, Teva Pharmaceutical, Merck, and Actavis, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Oral Contraceptive Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Long-acting Contraceptives
Short-acting Contraceptives
Emergency Contraceptives
Market segment by Application can be divided into
Hospital
Pharmacy
Other
The key market players for global Oral Contraceptive Drugs market are listed below:
Bayer
Pfizer
Teva Pharmaceutical
Merck
Actavis
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Contraceptive Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oral Contraceptive Drugs, with price, sales, revenue and global market share of Oral Contraceptive Drugs from 2019 to 2022.
Chapter 3, the Oral Contraceptive Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Contraceptive Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Oral Contraceptive Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Contraceptive Drugs.
Chapter 13, 14, and 15, to describe Oral Contraceptive Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Oral Contraceptive Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Contraceptive Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Long-acting Contraceptives
1.2.3 Short-acting Contraceptives
1.2.4 Emergency Contraceptives
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Contraceptive Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Oral Contraceptive Drugs Market Size & Forecast
1.4.1 Global Oral Contraceptive Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Oral Contraceptive Drugs Sales in Volume (2017-2028)
1.4.3 Global Oral Contraceptive Drugs Price (2017-2028)
1.5 Global Oral Contraceptive Drugs Production Capacity Analysis
1.5.1 Global Oral Contraceptive Drugs Total Production Capacity (2017-2028)
1.5.2 Global Oral Contraceptive Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Contraceptive Drugs Market Drivers
1.6.2 Oral Contraceptive Drugs Market Restraints
1.6.3 Oral Contraceptive Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Oral Contraceptive Drugs Product and Services
2.1.4 Bayer Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Oral Contraceptive Drugs Product and Services
2.2.4 Pfizer Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Teva Pharmaceutical
2.3.1 Teva Pharmaceutical Details
2.3.2 Teva Pharmaceutical Major Business
2.3.3 Teva Pharmaceutical Oral Contraceptive Drugs Product and Services
2.3.4 Teva Pharmaceutical Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Oral Contraceptive Drugs Product and Services
2.4.4 Merck Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Actavis
2.5.1 Actavis Details
2.5.2 Actavis Major Business
2.5.3 Actavis Oral Contraceptive Drugs Product and Services
2.5.4 Actavis Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Oral Contraceptive Drugs Product and Services
2.6.4 Johnson & Johnson Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Gedeon Richter
2.7.1 Gedeon Richter Details
2.7.2 Gedeon Richter Major Business
2.7.3 Gedeon Richter Oral Contraceptive Drugs Product and Services
2.7.4 Gedeon Richter Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novo Nordisk A/S
2.8.1 Novo Nordisk A/S Details
2.8.2 Novo Nordisk A/S Major Business
2.8.3 Novo Nordisk A/S Oral Contraceptive Drugs Product and Services
2.8.4 Novo Nordisk A/S Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 ZiZhu
2.9.1 ZiZhu Details
2.9.2 ZiZhu Major Business
2.9.3 ZiZhu Oral Contraceptive Drugs Product and Services
2.9.4 ZiZhu Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Baijingyu
2.10.1 Baijingyu Details
2.10.2 Baijingyu Major Business
2.10.3 Baijingyu Oral Contraceptive Drugs Product and Services
2.10.4 Baijingyu Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Huazhong
2.11.1 Huazhong Details
2.11.2 Huazhong Major Business
2.11.3 Huazhong Oral Contraceptive Drugs Product and Services
2.11.4 Huazhong Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Oral Contraceptive Drugs Breakdown Data by Manufacturer
3.1 Global Oral Contraceptive Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Oral Contraceptive Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Oral Contraceptive Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Contraceptive Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Oral Contraceptive Drugs Manufacturer Market Share in 2021
3.5 Global Oral Contraceptive Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Oral Contraceptive Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oral Contraceptive Drugs Market Size by Region
4.1.1 Global Oral Contraceptive Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Oral Contraceptive Drugs Revenue by Region (2017-2028)
4.2 North America Oral Contraceptive Drugs Revenue (2017-2028)
4.3 Europe Oral Contraceptive Drugs Revenue (2017-2028)
4.4 Asia-Pacific Oral Contraceptive Drugs Revenue (2017-2028)
4.5 South America Oral Contraceptive Drugs Revenue (2017-2028)
4.6 Middle East and Africa Oral Contraceptive Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Oral Contraceptive Drugs Sales in Volume by Type (2017-2028)
5.2 Global Oral Contraceptive Drugs Revenue by Type (2017-2028)
5.3 Global Oral Contraceptive Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Oral Contraceptive Drugs Sales in Volume by Application (2017-2028)
6.2 Global Oral Contraceptive Drugs Revenue by Application (2017-2028)
6.3 Global Oral Contraceptive Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Oral Contraceptive Drugs Sales by Type (2017-2028)
7.2 North America Oral Contraceptive Drugs Sales by Application (2017-2028)
7.3 North America Oral Contraceptive Drugs Market Size by Country
7.3.1 North America Oral Contraceptive Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Oral Contraceptive Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Oral Contraceptive Drugs Sales by Type (2017-2028)
8.2 Europe Oral Contraceptive Drugs Sales by Application (2017-2028)
8.3 Europe Oral Contraceptive Drugs Market Size by Country
8.3.1 Europe Oral Contraceptive Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Oral Contraceptive Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Oral Contraceptive Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Oral Contraceptive Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Oral Contraceptive Drugs Market Size by Region
9.3.1 Asia-Pacific Oral Contraceptive Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Oral Contraceptive Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Oral Contraceptive Drugs Sales by Type (2017-2028)
10.2 South America Oral Contraceptive Drugs Sales by Application (2017-2028)
10.3 South America Oral Contraceptive Drugs Market Size by Country
10.3.1 South America Oral Contraceptive Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Oral Contraceptive Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oral Contraceptive Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Oral Contraceptive Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Oral Contraceptive Drugs Market Size by Country
11.3.1 Middle East & Africa Oral Contraceptive Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Oral Contraceptive Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Oral Contraceptive Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Oral Contraceptive Drugs
12.3 Oral Contraceptive Drugs Production Process
12.4 Oral Contraceptive Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Oral Contraceptive Drugs Typical Distributors
13.3 Oral Contraceptive Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Oral Contraceptive Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Oral Contraceptive Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Oral Contraceptive Drugs Product and Services
Table 6. Bayer Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Oral Contraceptive Drugs Product and Services
Table 10. Pfizer Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Teva Pharmaceutical Major Business
Table 13. Teva Pharmaceutical Oral Contraceptive Drugs Product and Services
Table 14. Teva Pharmaceutical Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Oral Contraceptive Drugs Product and Services
Table 18. Merck Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Actavis Basic Information, Manufacturing Base and Competitors
Table 20. Actavis Major Business
Table 21. Actavis Oral Contraceptive Drugs Product and Services
Table 22. Actavis Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Oral Contraceptive Drugs Product and Services
Table 26. Johnson & Johnson Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table 28. Gedeon Richter Major Business
Table 29. Gedeon Richter Oral Contraceptive Drugs Product and Services
Table 30. Gedeon Richter Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 32. Novo Nordisk A/S Major Business
Table 33. Novo Nordisk A/S Oral Contraceptive Drugs Product and Services
Table 34. Novo Nordisk A/S Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. ZiZhu Basic Information, Manufacturing Base and Competitors
Table 36. ZiZhu Major Business
Table 37. ZiZhu Oral Contraceptive Drugs Product and Services
Table 38. ZiZhu Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Baijingyu Basic Information, Manufacturing Base and Competitors
Table 40. Baijingyu Major Business
Table 41. Baijingyu Oral Contraceptive Drugs Product and Services
Table 42. Baijingyu Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Huazhong Basic Information, Manufacturing Base and Competitors
Table 44. Huazhong Major Business
Table 45. Huazhong Oral Contraceptive Drugs Product and Services
Table 46. Huazhong Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Oral Contraceptive Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 48. Global Oral Contraceptive Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Oral Contraceptive Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Oral Contraceptive Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 51. Head Office and Oral Contraceptive Drugs Production Site of Key Manufacturer
Table 52. Oral Contraceptive Drugs New Entrant and Capacity Expansion Plans
Table 53. Oral Contraceptive Drugs Mergers & Acquisitions in the Past Five Years
Table 54. Global Oral Contraceptive Drugs Sales by Region (2017-2022) & (K MT)
Table 55. Global Oral Contraceptive Drugs Sales by Region (2023-2028) & (K MT)
Table 56. Global Oral Contraceptive Drugs Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Oral Contraceptive Drugs Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Oral Contraceptive Drugs Sales by Type (2017-2022) & (K MT)
Table 59. Global Oral Contraceptive Drugs Sales by Type (2023-2028) & (K MT)
Table 60. Global Oral Contraceptive Drugs Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Oral Contraceptive Drugs Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Oral Contraceptive Drugs Price by Type (2017-2022) & (K MT)
Table 63. Global Oral Contraceptive Drugs Price by Type (2023-2028) & (K MT)
Table 64. Global Oral Contraceptive Drugs Sales by Application (2017-2022) & (K MT)
Table 65. Global Oral Contraceptive Drugs Sales by Application (2023-2028) & (K MT)
Table 66. Global Oral Contraceptive Drugs Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Oral Contraceptive Drugs Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Oral Contraceptive Drugs Price by Application (2017-2022) & (K MT)
Table 69. Global Oral Contraceptive Drugs Price by Application (2023-2028) & (K MT)
Table 70. North America Oral Contraceptive Drugs Sales by Country (2017-2022) & (K MT)
Table 71. North America Oral Contraceptive Drugs Sales by Country (2023-2028) & (K MT)
Table 72. North America Oral Contraceptive Drugs Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Oral Contraceptive Drugs Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Oral Contraceptive Drugs Sales by Type (2017-2022) & (K MT)
Table 75. North America Oral Contraceptive Drugs Sales by Type (2023-2028) & (K MT)
Table 76. North America Oral Contraceptive Drugs Sales by Application (2017-2022) & (K MT)
Table 77. North America Oral Contraceptive Drugs Sales by Application (2023-2028) & (K MT)
Table 78. Europe Oral Contraceptive Drugs Sales by Country (2017-2022) & (K MT)
Table 79. Europe Oral Contraceptive Drugs Sales by Country (2023-2028) & (K MT)
Table 80. Europe Oral Contraceptive Drugs Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Oral Contraceptive Drugs Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Oral Contraceptive Drugs Sales by Type (2017-2022) & (K MT)
Table 83. Europe Oral Contraceptive Drugs Sales by Type (2023-2028) & (K MT)
Table 84. Europe Oral Contraceptive Drugs Sales by Application (2017-2022) & (K MT)
Table 85. Europe Oral Contraceptive Drugs Sales by Application (2023-2028) & (K MT)
Table 86. Asia-Pacific Oral Contraceptive Drugs Sales by Region (2017-2022) & (K MT)
Table 87. Asia-Pacific Oral Contraceptive Drugs Sales by Region (2023-2028) & (K MT)
Table 88. Asia-Pacific Oral Contraceptive Drugs Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Oral Contraceptive Drugs Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Oral Contraceptive Drugs Sales by Type (2017-2022) & (K MT)
Table 91. Asia-Pacific Oral Contraceptive Drugs Sales by Type (2023-2028) & (K MT)
Table 92. Asia-Pacific Oral Contraceptive Drugs Sales by Application (2017-2022) & (K MT)
Table 93. Asia-Pacific Oral Contraceptive Drugs Sales by Application (2023-2028) & (K MT)
Table 94. South America Oral Contraceptive Drugs Sales by Country (2017-2022) & (K MT)
Table 95. South America Oral Contraceptive Drugs Sales by Country (2023-2028) & (K MT)
Table 96. South America Oral Contraceptive Drugs Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Oral Contraceptive Drugs Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Oral Contraceptive Drugs Sales by Type (2017-2022) & (K MT)
Table 99. South America Oral Contraceptive Drugs Sales by Type (2023-2028) & (K MT)
Table 100. South America Oral Contraceptive Drugs Sales by Application (2017-2022) & (K MT)
Table 101. South America Oral Contraceptive Drugs Sales by Application (2023-2028) & (K MT)
Table 102. Middle East & Africa Oral Contraceptive Drugs Sales by Region (2017-2022) & (K MT)
Table 103. Middle East & Africa Oral Contraceptive Drugs Sales by Region (2023-2028) & (K MT)
Table 104. Middle East & Africa Oral Contraceptive Drugs Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Oral Contraceptive Drugs Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Oral Contraceptive Drugs Sales by Type (2017-2022) & (K MT)
Table 107. Middle East & Africa Oral Contraceptive Drugs Sales by Type (2023-2028) & (K MT)
Table 108. Middle East & Africa Oral Contraceptive Drugs Sales by Application (2017-2022) & (K MT)
Table 109. Middle East & Africa Oral Contraceptive Drugs Sales by Application (2023-2028) & (K MT)
Table 110. Oral Contraceptive Drugs Raw Material
Table 111. Key Manufacturers of Oral Contraceptive Drugs Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Oral Contraceptive Drugs Typical Distributors
Table 115. Oral Contraceptive Drugs Typical Customers
List of Figures
Figure 1. Oral Contraceptive Drugs Picture
Figure 2. Global Oral Contraceptive Drugs Revenue Market Share by Type in 2021
Figure 3. Long-acting Contraceptives
Figure 4. Short-acting Contraceptives
Figure 5. Emergency Contraceptives
Figure 6. Global Oral Contraceptive Drugs Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Pharmacy
Figure 9. Other
Figure 10. Global Oral Contraceptive Drugs Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 11. Global Oral Contraceptive Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Oral Contraceptive Drugs Sales (2017-2028) & (K MT)
Figure 13. Global Oral Contraceptive Drugs Price (2017-2028) & (K MT)
Figure 14. Global Oral Contraceptive Drugs Production Capacity (2017-2028) & (K MT)
Figure 15. Global Oral Contraceptive Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Oral Contraceptive Drugs Market Drivers
Figure 17. Oral Contraceptive Drugs Market Restraints
Figure 18. Oral Contraceptive Drugs Market Trends
Figure 19. Global Oral Contraceptive Drugs Sales Market Share by Manufacturer in 2021
Figure 20. Global Oral Contraceptive Drugs Revenue Market Share by Manufacturer in 2021
Figure 21. Oral Contraceptive Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Oral Contraceptive Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Oral Contraceptive Drugs Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Oral Contraceptive Drugs Sales Market Share by Region (2017-2028)
Figure 25. Global Oral Contraceptive Drugs Revenue Market Share by Region (2017-2028)
Figure 26. North America Oral Contraceptive Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Europe Oral Contraceptive Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Oral Contraceptive Drugs Revenue (2017-2028) & (USD Million)
Figure 29. South America Oral Contraceptive Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Oral Contraceptive Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Global Oral Contraceptive Drugs Sales Market Share by Type (2017-2028)
Figure 32. Global Oral Contraceptive Drugs Revenue Market Share by Type (2017-2028)
Figure 33. Global Oral Contraceptive Drugs Price by Type (2017-2028) & (K MT)
Figure 34. Global Oral Contraceptive Drugs Sales Market Share by Application (2017-2028)
Figure 35. Global Oral Contraceptive Drugs Revenue Market Share by Application (2017-2028)
Figure 36. Global Oral Contraceptive Drugs Price by Application (2017-2028) & (K MT)
Figure 37. North America Oral Contraceptive Drugs Sales Market Share by Type (2017-2028)
Figure 38. North America Oral Contraceptive Drugs Sales Market Share by Application (2017-2028)
Figure 39. North America Oral Contraceptive Drugs Sales Market Share by Country (2017-2028)
Figure 40. North America Oral Contraceptive Drugs Revenue Market Share by Country (2017-2028)
Figure 41. United States Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Oral Contraceptive Drugs Sales Market Share by Type (2017-2028)
Figure 45. Europe Oral Contraceptive Drugs Sales Market Share by Application (2017-2028)
Figure 46. Europe Oral Contraceptive Drugs Sales Market Share by Country (2017-2028)
Figure 47. Europe Oral Contraceptive Drugs Revenue Market Share by Country (2017-2028)
Figure 48. Germany Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Oral Contraceptive Drugs Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Oral Contraceptive Drugs Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Oral Contraceptive Drugs Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Oral Contraceptive Drugs Revenue Market Share by Region (2017-2028)
Figure 57. China Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Oral Contraceptive Drugs Sales Market Share by Type (2017-2028)
Figure 64. South America Oral Contraceptive Drugs Sales Market Share by Application (2017-2028)
Figure 65. South America Oral Contraceptive Drugs Sales Market Share by Country (2017-2028)
Figure 66. South America Oral Contraceptive Drugs Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Oral Contraceptive Drugs Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Oral Contraceptive Drugs Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Oral Contraceptive Drugs Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Oral Contraceptive Drugs Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Oral Contraceptive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Oral Contraceptive Drugs in 2021
Figure 78. Manufacturing Process Analysis of Oral Contraceptive Drugs
Figure 79. Oral Contraceptive Drugs Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の避妊薬及び避妊具市場2022年：市場規模予測（～2028年）
  • 世界の経口用緊急避妊ピル市場2022年：市場規模予測（～2028年）
  • 世界のメルカプトプリン内服薬市場2022年：市場規模予測（～2028年）
  • 世界のメトトレキサート（MTX）経口液市場2022年：市場規模予測（～2028年）
  • 世界の皮下型避妊インプラント市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19480 )"世界の経口避妊薬市場2022年：市場規模予測（～2028年）" (英文：Global Oral Contraceptive Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。